Invitation to take part in EVOLVE

Invitation to take part in EVOLVE: A study to develop a model of meaningful patient engagement within guideline development

You are invited to take part in an international Delphi study on patient involvement in clinical practice guideline development and implementation for prostate, bladder, kidney and testicular cancer in Europe. This study is sponsored by the University of Aberdeen, run by the Academic Urology Unit at the University of Aberdeen with endorsement from the European Association of Urology (EAU) Guidelines Office, and funded by North East Scotland urological cancer charity UCAN.

The EVOLVE study aims to determine the priority topic areas to be considered for patient involvement (i.e. areas where patient preferences and values are particularly important) within guideline development for prostate, bladder, kidney and testicular cancers in Europe. You are required to have expertise and experience in treating patients with urological cancers and experience in developing or using clinical practice guidelines.

Please read the attached Participant Information Sheet for full details of the study. If you decide to take part in this study you will be invited to participate in an online Delphi survey.

If you are interested in taking part in EVOLVE (Phase 3) or if you have any further questions about the study please contact the Research Fellow, Josefine Björkqvist, at

Best wishes,

Josefine Björkqvist